Back
Acumen Pharmaceuticals Vs. Kezar Life Sciences Industry Stock Comparison
Sell
36
ABOS
Acumen Pharmaceuticals
Last Price:
3.48
Seasonality Move:
68.9%
Sell
40
KZR
Kezar Life Sciences
Last Price:
0.86
Seasonality Move:
-20.11%
Sell
36
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy, Sell or Hold?
- The current Acumen Pharmaceuticals [ABOS] share price is $3.25. The Score for ABOS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ABOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Kezar Life Sciences (KZR)
is a Sell
Is Kezar Life Sciences a Buy, Sell or Hold?
- The current Kezar Life Sciences [KZR] share price is $0.84. The Score for KZR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- KZR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABOS Stock Price Chart
What is Acumen Pharmaceuticals's stock price today?
-
The Acumen Pharmaceuticals share price today is $3.25
The current trend is relatively stagnant and ABOS is experiencing slight selling pressure.
KZR Stock Price Chart
What is Kezar Life Sciences's stock price today?
-
The Kezar Life Sciences share price today is $0.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KZR is experiencing slight buying pressure.
ABOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 38.06 | Sell |
| Chaikin Money Flow: | -12691 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.22 - 3.9) | Sell |
| Bollinger Bands (100): | (3.13 - 4.11) | Sell |
KZR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 49.76 | Sell |
| Chaikin Money Flow: | 290779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.79 - 0.87) | Buy |
| Bollinger Bands (100): | (0.82 - 0.94) | Sell |
ABOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.18 | Buy |
| 20-day SMA: | 3.45 | Sell |
| 50-day SMA: | 3.84 | Sell |
| 200-day SMA: | 4.14 | Sell |
| 8-day EMA: | 3.24 | Buy |
| 20-day EMA: | 3.42 | Sell |
| 50-day EMA: | 3.6 | Sell |
| 200-day EMA: | 4.01 | Sell |
KZR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Buy |
| 20-day SMA: | 0.81 | Buy |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 1.08 | Sell |
| 8-day EMA: | 0.82 | Buy |
| 20-day EMA: | 0.83 | Buy |
| 50-day EMA: | 0.86 | Sell |
| 200-day EMA: | 1.48 | Sell |
Acumen Pharmaceuticals Earnings Growth & ABOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.15 per share.
Kezar Life Sciences Earnings Growth & KZR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.16 per share.
Acumen Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kezar Life Sciences Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||